Spironolactone 50 MG

DRUG3 trials

Sponsors

Dr Irmela MANTEL, Medical University of South Carolina, Wake Forest University Health Sciences

Conditions

Diabetic MaculopathyHidradenitis SuppurativaNeovascular Age-related Macular Degeneration

Phase 2

Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration

CompletedNCT03744767

Dr Irmela MANTELNeovascular Age-related Macular Degeneration

Start: 2014-09-19End: 2015-09-22Updated: 2018-11-16

Phase 4

Spironolactone for Hidradenitis Suppurativa

WithdrawnNCT04100083

Medical University of South CarolinaHidradenitis Suppurativa

Start: 2020-09-21End: 2021-06-21Updated: 2024-09-19

Non-Responsive Diabetic Macular Edema and Spironolactone

WithdrawnNCT04853355

Wake Forest University Health SciencesDiabetic Maculopathy

Start: 2022-07-31End: 2022-10-31Updated: 2022-08-02